ITP
OM icon

Iron Triangle Partners’s Outset Medical OM Stock Holding History

Iron Triangle Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,667
Closed -$5.44M – 32
2021
Q1 		$5.44M Sell
6,667
-3,333
-33% -$2.57M 0.69% 26
2020
Q4 		$8.53M Hold
10,000
– – 1.11% 25
2020
Q3 		$7.5M Buy
+10,000
New +$8.21M 1.68% 22

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Iron Triangle Partners's OM Position: Q2 2021 in Review

Iron Triangle Partners sold out of Outset Medical (OM) in Q2 2021, closing a stake of 6,667 shares — an estimated $5.44M sold.

Iron Triangle Partners first reported a position in OM in Q3 2020 and held it in 3 quarters. The position peaked at $8.53M in Q4 2020. 129 funds tracked by Wall St. Rank hold OM as of Q2 2021.

  • Iron Triangle Partners reported no remaining Outset Medical position as of Q2 2021 after selling out during the quarter.
  • Iron Triangle Partners sold 6,667 Outset Medical shares in Q2 2021, an estimated $5.44M.
  • Iron Triangle Partners first reported a position in Outset Medical in Q3 2020 and held it in 3 quarters.
  • Iron Triangle Partners's Outset Medical position peaked at $8.53M in Q4 2020.
  • 129 funds tracked by Wall St. Rank held Outset Medical as of Q2 2021.

Based on Iron Triangle Partners's 13F filing for Q2 2021, filed 16 Aug 2021.